Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sangamo Biosciences (SGMO)
NASDAQ:SGMO
Sangamo Biosciences (SGMO) Stock Price & Analysis
1,455 Followers
SGMO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.49 - $4.80
Previous Close$0.58
Volume1.02M
Average Volume (3M)1.83M
Market Cap
$102.25M
Enterprise Value-$4.48M
Total Cash (Recent Filing)$143.10M
Total Debt (Recent Filing)$36.37M
Price to Earnings (P/E)-0.5
Beta1.47
Next Earnings
Nov 08, 2023EPS Estimate
-$0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.18
Shares Outstanding177,111,718
10 Day Avg. Volume3,684,875
30 Day Avg. Volume1,833,824
Standard Deviation0.19
R-Squared0.12
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.42
Price to Sales (P/S)14.96
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.02
Enterprise Value/Gross Profit-0.04
Enterprise Value/Ebitda0.02
Forecast
1Y Price Target
$6.37Price Target Upside1088.43% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Sangamo Biosciences News
Pre-EarningsSGMO Upcoming Earnings Report: What to Expect?
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SGMO FAQ
What was Sangamo Biosciences’s price range in the past 12 months?
Sangamo Biosciences lowest stock price was $0.49 and its highest was $4.80 in the past 12 months.
What is Sangamo Biosciences’s market cap?
Currently, no data Available
When is Sangamo Biosciences’s upcoming earnings report date?
Sangamo Biosciences’s upcoming earnings report date is Nov 08, 2023 which is in 20 days.
How were Sangamo Biosciences’s earnings last quarter?
Sangamo Biosciences released its earnings results on Aug 08, 2023. The company reported -$0.66 earnings per share for the quarter, missing the consensus estimate of -$0.336 by -$0.324.
Is Sangamo Biosciences overvalued?
According to Wall Street analysts Sangamo Biosciences’s price is currently Undervalued.
Does Sangamo Biosciences pay dividends?
Sangamo Biosciences does not currently pay dividends.
What is Sangamo Biosciences’s EPS estimate?
Sangamo Biosciences’s EPS estimate is -$0.32.
How many shares outstanding does Sangamo Biosciences have?
Sangamo Biosciences has 177,111,720 shares outstanding.
What happened to Sangamo Biosciences’s price movement after its last earnings report?
Sangamo Biosciences reported an EPS of -$0.66 in its last earnings report, missing expectations of -$0.336. Following the earnings report the stock price went down -7.895%.
Which hedge fund is a major shareholder of Sangamo Biosciences?
Among the largest hedge funds holding Sangamo Biosciences’s share is Caxton Associates LP. It holds Sangamo Biosciences’s shares valued at 231K.
---
Sangamo Biosciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.37 (1088.43% Upside)
$6.37 (1088.43% Upside)
Blogger Sentiment
Bullish
SGMO Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 42.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days <0.1%
Last 30 Days ▲ 0.4%
Last 30 Days ▲ 0.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-87.97%
12-Months-Change
Fundamentals
Return on Equity
-71.93%
Trailing 12-Months
Asset Growth
-47.32%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Sangamo Biosciences
Sangamo Therapeutics, Inc. engages in researching and developing transcription factors in the regulation of genes. It focuses on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering of a class of transcription factors known as zinc finger DNA-binding proteins. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.
---
Top 5 ETFs holding SGMO
Vanguard Total Stock Market ETF
$2.57M
Vanguard Health Care ETF
$321.15K
Schwab U.S. Broad Market ETF
$60.13K
iShares Russell 3000 ETF
$18.67K
Vanguard Russell 3000 ETF
$7.27K
Up to five ETFs with an Outperform Smart Score that hold SGMO. The ETFs are listed according to market value of SGMO within the ETF
---